Display Settings:

Format

Send to:

Choose Destination
JAMA Neurol. 2013 Jan;70(1):117-9. doi: 10.1001/jamaneurol.2013.585.

Persistent intrathecal antibody synthesis 15 years after recovering from anti-N-methyl-D-aspartate receptor encephalitis.

Author information

  • 1Department of Neurology and Psychiatry, Friedrich-Ebert-Hospital, Neumünster, Germany.

Abstract

BACKGROUND:

Anti- N-methyl-D-aspartate receptor (NMDAR) encephalitis is a severe autoimmune disorder characterized by high intrathecal antibody synthesis. Little is known about the long-term follow-up of the cerebrospinal fluid antibody status.

OBJECTIVE:

To describe persistent intrathecal antibody synthesis in a clinically healthy person 15 years after recovering from anti-NMDAR encephalitis.

DESIGN:

Case report.

SETTING:

Academic medical center.

PATIENT:

A 40-year-old woman who had been diagnosed as having encephalitis of unknown origin in 1995.

MAIN OUTCOME MEASURES:

Clinical evaluation and NMDAR antibody testing.

RESULTS:

On reexamination in 2011, the patient had fully recovered. Investigation of archived as well as follow-up serum and cerebrospinal fluid samples revealed intrathecal synthesis of NMDAR antibodies.

CONCLUSIONS:

This is the longest follow-up on a patient with anti-NMDAR encephalitis. Our findings emphasize that intrathecal antibody synthesis does not necessarily reflect disease activity and that the significance of NMDAR antibody titers needs to be interpreted for each patient according to the clinical context.

PMID:
23318518
[PubMed - indexed for MEDLINE]
PMCID:
PMC3707142
Free PMC Article

Images from this publication.See all images (2)Free text

Figure 1
Figure 2
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems Icon for PubMed Central
    Loading ...
    Write to the Help Desk